
Studies indicate that dupilumab, when combined with topical corticosteroids, is effective in achieving significant clinical endpoints such as IGA 0/1 and EASI-75 in patients with atopic dermatitis.
atopic, achieving, dupilumab, effective, easi, treated, topical, patients, iga, dermatitis, corticosteroids
atopic, achieving, dupilumab, effective, easi, treated, topical, patients, iga, dermatitis, corticosteroids
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
